 | • レポートコード：GIR-105X02343 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ベリムマブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ベリムマブの種類別市場規模（400mg注射、120mg注射）、用途別市場規模（病院、ドラッグセンター、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ベリムマブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GlaxoSmithKline ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：400mg注射、120mg注射 ・用途別分析2016年-2026年：病院、ドラッグセンター、クリニック、その他 ・ベリムマブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ベリムマブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ベリムマブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ベリムマブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ベリムマブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Belimumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Belimumab size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Belimumab market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Belimumab market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
400mg Injection
120mg Injection
Market segment by Application can be divided into
Hospital
Drug Center
Clinic
Other
The key market players for global Belimumab market are listed below:
GlaxoSmithKline
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Belimumab Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Belimumab Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 400mg Injection
1.2.3 120mg Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Belimumab Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Drug Center
1.3.4 Clinic
1.3.5 Other
1.4 Global Belimumab Market Size & Forecast
1.4.1 Global Belimumab Sales in Value (2016-2026))
1.4.2 Global Belimumab Sales in Volume (2016-2026)
1.4.3 Global Belimumab Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Belimumab Production Capacity Analysis
1.5.1 Global Belimumab Total Production Capacity (2016-2026)
1.5.2 Global Belimumab Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Belimumab Market Drivers
1.6.2 Belimumab Market Restraints
1.6.3 Belimumab Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Belimumab Product and Services
2.1.4 GlaxoSmithKline Belimumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Belimumab Sales by Manufacturer
3.1 Global Belimumab Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Belimumab Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Belimumab
3.4 Market Concentration Rate
3.4.1 Top 3 Belimumab Manufacturer Market Share
3.4.2 Top 6 Belimumab Manufacturer Market Share
3.5 Global Belimumab Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Belimumab Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Belimumab Market Size by Region
4.1.1 Global Belimumab Sales in Volume by Region (2016-2026)
4.1.2 Global Belimumab Revenue by Region (2016-2026)
4.2 North America Belimumab Revenue (2016-2026)
4.3 Europe Belimumab Revenue (2016-2026)
4.4 Asia-Pacific Belimumab Revenue (2016-2026)
4.5 South America Belimumab Revenue (2016-2026)
4.6 Middle East and Africa Belimumab Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Belimumab Sales in Volume by Type (2016-2026)
5.2 Global Belimumab Revenue by Type (2016-2026)
5.3 Global Belimumab Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Belimumab Sales in Volume by Application (2016-2026)
6.2 Global Belimumab Revenue by Application (2016-2026)
6.3 Global Belimumab Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Belimumab Sales by Type (2016-2026)
7.2 North America Belimumab Sales by Application (2016-2026)
7.3 North America Belimumab Market Size by Country
7.3.1 North America Belimumab Sales in Volume by Country (2016-2026)
7.3.2 North America Belimumab Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Belimumab Sales by Type (2016-2026)
8.2 Europe Belimumab Sales by Application (2016-2026)
8.3 Europe Belimumab Market Size by Country
8.3.1 Europe Belimumab Sales in Volume by Country (2016-2026)
8.3.2 Europe Belimumab Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Belimumab Sales by Type (2016-2026)
9.2 Asia-Pacific Belimumab Sales by Application (2016-2026)
9.3 Asia-Pacific Belimumab Market Size by Region
9.3.1 Asia-Pacific Belimumab Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Belimumab Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Belimumab Sales by Type (2016-2026)
10.2 South America Belimumab Sales by Application (2016-2026)
10.3 South America Belimumab Market Size by Country
10.3.1 South America Belimumab Sales in Volume by Country (2016-2026)
10.3.2 South America Belimumab Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Belimumab Sales by Type (2016-2026)
11.2 Middle East & Africa Belimumab Sales by Application (2016-2026)
11.3 Middle East & Africa Belimumab Market Size by Country
11.3.1 Middle East & Africa Belimumab Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Belimumab Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Belimumab Typical Distributors
12.3 Belimumab Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Belimumab Revenue by Type, (USD Million), 2021-2026
Table 2. Global Belimumab Revenue by Application, (USD Million), 2021-2026
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Belimumab Product and Services
Table 6. GlaxoSmithKline Belimumab Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Global Belimumab Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 8. Global Belimumab Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 9. Market Position of Manufacturers in Belimumab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 10. Global Belimumab Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 11. Head Office and Belimumab Production Site of Key Manufacturer
Table 12. Global Belimumab Sales by Region (2016-2021e) & (K Pcs)
Table 13. Global Belimumab Sales by Region (2021-2026) & (K Pcs)
Table 14. Global Belimumab Revenue by Region (2016-2021e) & (USD Million)
Table 15. Global Belimumab Revenue by Region (2021-2026) & (USD Million)
Table 16. Global Belimumab Sales by Type (2016-2021e) & (K Pcs)
Table 17. Global Belimumab Sales by Type (2021-2026) & (K Pcs)
Table 18. Global Belimumab Revenue by Type (2016-2021e) & (USD Million)
Table 19. Global Belimumab Revenue by Type (2021-2026) & (USD Million)
Table 20. Global Belimumab Price by Type (2016-2021e) & (USD/Pcs)
Table 21. Global Belimumab Price by Type (2021-2026) & (USD/Pcs)
Table 22. Global Belimumab Sales by Application (2016-2021e) & (K Pcs)
Table 23. Global Belimumab Sales by Application (2021-2026) & (K Pcs)
Table 24. Global Belimumab Revenue by Application (2016-2021e) & (USD Million)
Table 25. Global Belimumab Revenue by Application (2021-2026) & (USD Million)
Table 26. Global Belimumab Price by Application (2016-2021e) & (USD/Pcs)
Table 27. Global Belimumab Price by Application (2021-2026) & (USD/Pcs)
Table 28. North America Belimumab Sales by Country (2016-2021e) & (K Pcs)
Table 29. North America Belimumab Sales by Country (2021-2026) & (K Pcs)
Table 30. North America Belimumab Revenue by Country (2016-2021e) & (USD Million)
Table 31. North America Belimumab Revenue by Country (2021-2026) & (USD Million)
Table 32. North America Belimumab Sales by Type (2016-2021e) & (K Pcs)
Table 33. North America Belimumab Sales by Type (2021-2026) & (K Pcs)
Table 34. North America Belimumab Sales by Application (2016-2021e) & (K Pcs)
Table 35. North America Belimumab Sales by Application (2021-2026) & (K Pcs)
Table 36. Europe Belimumab Sales by Country (2016-2021e) & (K Pcs)
Table 37. Europe Belimumab Sales by Country (2021-2026) & (K Pcs)
Table 38. Europe Belimumab Revenue by Country (2016-2021e) & (USD Million)
Table 39. Europe Belimumab Revenue by Country (2021-2026) & (USD Million)
Table 40. Europe Belimumab Sales by Type (2016-2021e) & (K Pcs)
Table 41. Europe Belimumab Sales by Type (2021-2026) & (K Pcs)
Table 42. Europe Belimumab Sales by Application (2016-2021e) & (K Pcs)
Table 43. Europe Belimumab Sales by Application (2021-2026) & (K Pcs)
Table 44. Asia-Pacific Belimumab Sales by Region (2016-2021e) & (K Pcs)
Table 45. Asia-Pacific Belimumab Sales by Region (2021-2026) & (K Pcs)
Table 46. Asia-Pacific Belimumab Revenue by Region (2016-2021e) & (USD Million)
Table 47. Asia-Pacific Belimumab Revenue by Region (2021-2026) & (USD Million)
Table 48. Asia-Pacific Belimumab Sales by Type (2016-2021e) & (K Pcs)
Table 49. Asia-Pacific Belimumab Sales by Type (2021-2026) & (K Pcs)
Table 50. Asia-Pacific Belimumab Sales by Application (2016-2021e) & (K Pcs)
Table 51. Asia-Pacific Belimumab Sales by Application (2021-2026) & (K Pcs)
Table 52. South America Belimumab Sales by Country (2016-2021e) & (K Pcs)
Table 53. South America Belimumab Sales by Country (2021-2026) & (K Pcs)
Table 54. South America Belimumab Revenue by Country (2016-2021e) & (USD Million)
Table 55. South America Belimumab Revenue by Country (2021-2026) & (USD Million)
Table 56. South America Belimumab Sales by Type (2016-2021e) & (K Pcs)
Table 57. South America Belimumab Sales by Type (2021-2026) & (K Pcs)
Table 58. South America Belimumab Sales by Application (2016-2021e) & (K Pcs)
Table 59. South America Belimumab Sales by Application (2021-2026) & (K Pcs)
Table 60. Middle East & Africa Belimumab Sales by Country (2016-2021e) & (K Pcs)
Table 61. Middle East & Africa Belimumab Sales by Country (2021-2026) & (K Pcs)
Table 62. Middle East & Africa Belimumab Revenue by Country (2016-2021e) & (USD Million)
Table 63. Middle East & Africa Belimumab Revenue by Country (2021-2026) & (USD Million)
Table 64. Middle East & Africa Belimumab Sales by Type (2016-2021e) & (K Pcs)
Table 65. Middle East & Africa Belimumab Sales by Type (2021-2026) & (K Pcs)
Table 66. Middle East & Africa Belimumab Sales by Application (2016-2021e) & (K Pcs)
Table 67. Middle East & Africa Belimumab Sales by Application (2021-2026) & (K Pcs)
Table 68. Direct Channel Pros & Cons
Table 69. Indirect Channel Pros & Cons
Table 70. Belimumab Typical Distributors
Table 71. Belimumab Typical Customers
List of Figures
Figure 1. Belimumab Picture
Figure 2. Global Belimumab Sales Market Share by Type in 2020
Figure 3. 400mg Injection
Figure 4. 120mg Injection
Figure 5. Global Belimumab Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Drug Center
Figure 8. Clinic
Figure 9. Other
Figure 10. Global Belimumab Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 11. Global Belimumab Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Belimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Belimumab Sales (2016-2026) & (K Pcs)
Figure 32. Global Belimumab Production Capacity (2016-2026) & (K Pcs)
Figure 33. Global Belimumab Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Belimumab Market Drivers
Figure 35. Belimumab Market Restraints
Figure 36. Belimumab Market Trends
Figure 37. Global Belimumab Sales Market Share by Manufacturer in 2020
Figure 38. Global Belimumab Revenue Market Share by Manufacturer in 2020
Figure 39. Belimumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Belimumab Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Belimumab Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Belimumab Sales Market Share by Region (2016-2026)
Figure 43. Global Belimumab Revenue Market Share by Region (2016-2026)
Figure 44. North America Belimumab Revenue (2016-2026) & (USD Million)
Figure 45. Europe Belimumab Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Belimumab Revenue (2016-2026) & (USD Million)
Figure 47. South America Belimumab Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Belimumab Revenue (2016-2026) & (USD Million)
Figure 49. Global Belimumab Sales Market Share by Type (2016-2026)
Figure 50. Global Belimumab Revenue Market Share by Type (2016-2026)
Figure 51. Global Belimumab Price by Type (2016-2026) & (USD/Pcs)
Figure 52. Global Belimumab Sales Market Share by Application (2016-2026)
Figure 53. Global Belimumab Revenue Market Share by Application (2016-2026)
Figure 54. Global Belimumab Price by Application (2016-2026) & (USD/Pcs)
Figure 55. North America Belimumab Sales Market Share by Country (2016-2026)
Figure 56. North America Belimumab Revenue Market Share by Country (2016-2026)
Figure 57. North America Belimumab Sales Market Share by Type (2016-2026)
Figure 58. North America Belimumab Sales Market Share by Application (2016-2026)
Figure 59. Europe Belimumab Sales Market Share by Country (2016-2026)
Figure 60. Europe Belimumab Revenue Market Share by Country (2016-2026)
Figure 61. Europe Belimumab Sales Market Share by Type (2016-2026)
Figure 62. Europe Belimumab Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Belimumab Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Belimumab Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Belimumab Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Belimumab Sales Market Share by Application (2016-2026)
Figure 67. South America Belimumab Sales Market Share by Country (2016-2026)
Figure 68. South America Belimumab Revenue Market Share by Country (2016-2026)
Figure 69. South America Belimumab Sales Market Share by Type (2016-2026)
Figure 70. South America Belimumab Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Belimumab Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Belimumab Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Belimumab Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Belimumab Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の注射用オマリズマブ市場 2021：企業別、地域別、種類・用途別 The Omalizumab for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…- 世界のビンポセチン注射市場 2021：企業別、地域別、種類・用途別 The Vinpocetine Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 無針薬物注射システムの世界市場2018-2025 Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas …
- 世界のオキシラセタム注射市場 2021：企業別、地域別、種類・用途別 The Oxiracetam Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界のエダラボン注射市場 2021：企業別、地域別、種類・用途別 The Edaravone Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…